Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for chronic central neuropathic pain after spinal cord injury
2008-008339-27Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in central neuropathic pain (CNP) and Neuralgia comparing Pregabalin with Placebo (2 arms). Primary endpoint: Duration adjusted average change in daily pain score. Started Mar 2009; status: completed.
02
Drugs
pregabalin
03
Conditions
central neuropathic pain (CNP)Neuralgia
Beyond the preview
Go deeper on 2008-008339-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008339-27.